Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
26 hedge funds and large institutions have $69.5M invested in Augmedix, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$52.1M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$2.51M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.22M |
| 4 |
AFG
American Financial Group
Cincinnati,
Ohio
|
+$1.81M |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.55M |
Top Sellers
AUGX Hedge Fund Activity: Q4 2021 in Review
26 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q4 2021, worth a combined $69.5M.
Buyers outnumbered sellers: 26 funds opened new AUGX positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Redmile Group, opening a new position worth an estimated $52.1M.
- 26 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $69.5M of Augmedix, Inc. Common Stock stock for Q4 2021.
- 26 funds opened new Augmedix, Inc. Common Stock positions in Q4 2021 and 0 closed out, a net change of +26 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q4 2021 was Redmile Group, an estimated $52.1M added.
Based on aggregated 13F filings for Q4 2021.